ArticleBlood advances2025

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.

Peter A Riedell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.